Publicaciones en colaboración con investigadores/as de University of Rome Tor Vergata (208)

2024

  1. Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry

    Journal of the American Heart Association, Vol. 13, Núm. 4, pp. e030623

  2. Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium

    The Lancet HIV, Vol. 11, Núm. 10, pp. e700-e710

  3. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71

  4. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry

    Haematologica

  5. Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study

    RMD Open, Vol. 10, Núm. 3

  6. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

    Genome medicine

  7. Family History in the Iberian Peninsula during Chalcolithic and Bronze Age: An Interpretation through the Genetic Analysis of Plural Burials

    Genealogy, Vol. 8, Núm. 1

  8. High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries

    eClinicalMedicine, Vol. 73

  9. Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART

    Frontiers in Immunology, Vol. 15

  10. Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1796-1802

  11. Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission

    Nature Medicine, Vol. 30, Núm. 10, pp. 2796-2804

2023

  1. A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets

    Neurodegenerative Disease Management, Vol. 13, Núm. 1, pp. 15-21

  2. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 4, pp. 984-996.e10

  3. An international comparative analysis and roadmap to sustainable biosimilar markets

    Frontiers in Pharmacology, Vol. 14

  4. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products

    Clinical and experimental rheumatology, Vol. 41, Núm. 3, pp. 543-553

  5. Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile

    Pediatric Research, Vol. 94, Núm. 5, pp. 1667-1674

  6. Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence

    Multiple Sclerosis and Related Disorders, Vol. 69

  7. How Mitochondrial DNA Can Write Pre-History: Kinship and Culture in Duero Basin (Spain) during Chalcolithic and Bronze Age

    Genealogy, Vol. 7, Núm. 3

  8. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

    International Journal of Antimicrobial Agents, Vol. 62, Núm. 4

  9. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

    eClinicalMedicine, Vol. 58